• Something wrong with this record ?

The quercetin metabolite 4-methylcatechol causes vasodilation via voltage-gated potassium (KV) channels

P. Dias, R. Salam, J. Pourová, M. Vopršalová, L. Konečný, E. Jirkovský, J. Duintjer Tebbens, P. Mladěnka

. 2024 ; 15 (22) : 11047-11059. [pub] 20241111

Language English Country England, Great Britain

Document type Journal Article

Dietary polyphenols have been associated with many beneficial cardiovascular effects. However, these effects are rather attributed to small phenolic metabolites formed by the gut microbiota, which reach sufficient concentrations in systemic circulation. 4-Methylcatechol (4-MC) is one such metabolite. As it is shown to possess considerable vasorelaxant effects, this study aimed to unravel its mechanism of action. To this end, experimental in vitro and in silico approaches were employed. In the first step, isometric tension recordings were performed on rat aortic rings. 4-MC potentiated the effect of cyclic nucleotides, but the effect was not mediated by either soluble guanylyl cyclase (sGC), modification of cyclic adenosine monophosphate levels, or protein kinase G. Hence, downstream targets such as calcium or potassium channels were considered. Inhibition of voltage-gated K+ channels (KV) markedly decreased the effect of 4-MC, and vasodilation was partly decreased by inhibition of the KV7 isoform. Contrarily, other types of K+ channels or L-type Ca2+ channels were not involved. In silico reverse docking confirmed that 4-MC binds to KV7.4 through hydrogen bonding and hydrophobic interactions. In particular, it interacts with two crucial residues for KV7.4 activation: Trp242 and Phe246. In summary, our findings suggested that 4-MC exerts vasorelaxation by opening KV channels with the involvement of KV7.4.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25003483
003      
CZ-PrNML
005      
20250206104353.0
007      
ta
008      
250121s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1039/d3fo04672a $2 doi
035    __
$a (PubMed)39422021
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Dias, Patrícia $u Department of Pharmacology and Toxicology, Faculty of Pharmacy, Charles University, Hradec Kralove, 500 05, Czech Republic. mladenkap@faf.cuni.cz $u Division of Outcomes & Translational Sciences, Pelotonia Research Center, The Ohio State University, 2255 Kenny Rd, Columbus, OH, USA
245    14
$a The quercetin metabolite 4-methylcatechol causes vasodilation via voltage-gated potassium (KV) channels / $c P. Dias, R. Salam, J. Pourová, M. Vopršalová, L. Konečný, E. Jirkovský, J. Duintjer Tebbens, P. Mladěnka
520    9_
$a Dietary polyphenols have been associated with many beneficial cardiovascular effects. However, these effects are rather attributed to small phenolic metabolites formed by the gut microbiota, which reach sufficient concentrations in systemic circulation. 4-Methylcatechol (4-MC) is one such metabolite. As it is shown to possess considerable vasorelaxant effects, this study aimed to unravel its mechanism of action. To this end, experimental in vitro and in silico approaches were employed. In the first step, isometric tension recordings were performed on rat aortic rings. 4-MC potentiated the effect of cyclic nucleotides, but the effect was not mediated by either soluble guanylyl cyclase (sGC), modification of cyclic adenosine monophosphate levels, or protein kinase G. Hence, downstream targets such as calcium or potassium channels were considered. Inhibition of voltage-gated K+ channels (KV) markedly decreased the effect of 4-MC, and vasodilation was partly decreased by inhibition of the KV7 isoform. Contrarily, other types of K+ channels or L-type Ca2+ channels were not involved. In silico reverse docking confirmed that 4-MC binds to KV7.4 through hydrogen bonding and hydrophobic interactions. In particular, it interacts with two crucial residues for KV7.4 activation: Trp242 and Phe246. In summary, our findings suggested that 4-MC exerts vasorelaxation by opening KV channels with the involvement of KV7.4.
650    _2
$a zvířata $7 D000818
650    12
$a vazodilatace $x účinky léků $7 D014664
650    12
$a katecholy $x farmakologie $7 D002396
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a mužské pohlaví $7 D008297
650    12
$a draslíkové kanály řízené napětím $x metabolismus $7 D024642
650    12
$a quercetin $x farmakologie $7 D011794
650    _2
$a simulace molekulového dockingu $7 D062105
650    _2
$a potkani Wistar $7 D017208
650    _2
$a vazodilatancia $x farmakologie $7 D014665
650    _2
$a aorta $x účinky léků $x metabolismus $7 D001011
655    _2
$a časopisecké články $7 D016428
700    1_
$a Salam, Rudy $u Department of Biophysics and Physical Chemistry, Faculty of Pharmacy, Charles University, Hradec Kralove, 500 05, Czech Republic $u Department of Pharmacy, Faculty of Medicine, Brawijaya University, Malang, Indonesia $1 https://orcid.org/0009000558795752
700    1_
$a Pourová, Jana $u Department of Pharmacology and Toxicology, Faculty of Pharmacy, Charles University, Hradec Kralove, 500 05, Czech Republic. mladenkap@faf.cuni.cz $1 https://orcid.org/0000000207284646 $7 jx20091104012
700    1_
$a Vopršalová, Marie $u Department of Pharmacology and Toxicology, Faculty of Pharmacy, Charles University, Hradec Kralove, 500 05, Czech Republic. mladenkap@faf.cuni.cz
700    1_
$a Konečný, Lukáš $u Department of Pharmacology and Toxicology, Faculty of Pharmacy, Charles University, Hradec Kralove, 500 05, Czech Republic. mladenkap@faf.cuni.cz
700    1_
$a Jirkovský, Eduard $u Department of Pharmacology and Toxicology, Faculty of Pharmacy, Charles University, Hradec Kralove, 500 05, Czech Republic. mladenkap@faf.cuni.cz $1 https://orcid.org/0000000342864811 $7 uk20201094982
700    1_
$a Duintjer Tebbens, Jurjen $u Department of Biophysics and Physical Chemistry, Faculty of Pharmacy, Charles University, Hradec Kralove, 500 05, Czech Republic $1 https://orcid.org/000000030553854X $7 xx0022491
700    1_
$a Mladěnka, Přemysl $u Department of Pharmacology and Toxicology, Faculty of Pharmacy, Charles University, Hradec Kralove, 500 05, Czech Republic. mladenkap@faf.cuni.cz $1 https://orcid.org/0000000260766900 $7 xx0233006
773    0_
$w MED00184541 $t Food & function $x 2042-650X $g Roč. 15, č. 22 (2024), s. 11047-11059
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39422021 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250121 $b ABA008
991    __
$a 20250206104349 $b ABA008
999    __
$a ok $b bmc $g 2263321 $s 1239490
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 15 $c 22 $d 11047-11059 $e 20241111 $i 2042-650X $m Food & function $n Food Funct $x MED00184541
LZP    __
$a Pubmed-20250121

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...